Mupirocin Infectopharm (Mupirocin)

Mupirocin blocks the bacterial enzyme isoleucyl‑tRNA synthetase, which is required for protein synthesis. By inhibiting this step, the drug stops bacterial growth and leads to cell death, providing effective antibacterial activity against Gram‑positive organisms.

The dosing regimen for Mupirocin Infectopharm is determined by the prescribing clinician based on the specific indication, patient age, and clinical circumstances. The prescriber will provide detailed instructions on amount, frequency, and duration of application.

Safety data for mupirocin during pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mupirocin offers a unique mechanism by inhibiting isoleucyl‑tRNA synthetase, providing strong activity against MRSA and other resistant Gram‑positive bacteria. Alternatives such as fusidic acid or bacitracin have different spectra and resistance profiles, making mupirocin a preferred choice for nasal decolonisation of resistant Staphylococcus aureus.

Store the ointment at temperatures below 25 °C in its original container, protecting it from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures that could affect its stability.

The ointment is applied intranasally using a clean fingertip or applicator. The prescriber will specify the amount (typically a small ribbon of ointment) and frequency, usually twice daily, for the duration recommended for the particular indication.

Serious adverse reactions, though rare, include allergic contact dermatitis, anaphylaxis, and severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. Immediate medical attention is required if signs of a severe allergic response develop.

Individuals with a known hypersensitivity to mupirocin or any component of the formulation should avoid its use. Additionally, patients with severe liver or kidney impairment should consult their healthcare provider before treatment, as should those taking interacting medications as listed in the interaction section.